Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
Published Date: 14 Jul 2023
The first treatment of its kind that interferes with the metabolism and release of prostate cancer cells has been created, according to researchers publishing in ACS Central Science.
Read Full News(Corrects executive's name from Alaa Ahmed to Alaa Hamed in paragraphs 7 and 8)
Ethicist Art Caplan discusses a recent case involving attempted suicide and advance directives
Spinal anesthesia offers faster recovery, similar OR time, and significantly less opioid use, with no increase in cost or OR delays.
A single injection of bevacizumab given during glaucoma surgery is associated with improved chances of surgical success even 3 years after the operation, a follow-up study of a clinical trial shows.
Dozens of state anti-vaccine bills backed by "Make America Healthy Again" supporters have failed after public health groups won over Republican state lawmakers, marking a...
The U.S. health department has withdrawn an April charter renewal for a key vaccine advisory panel that laid out new membership rules and direction, citing an...
Britain has received supplies of the antiviral drug favipiravir from Japan as part of its response to a deadly hantavirus outbreak linked to the Hondius cruise liner, the...
1.
improvements in the treatment of prostate cancer resistant to chemotherapy.
2.
More cancer cases in areas where incarceration rates are high: Study
3.
Early breast cancer detection may be possible with a wearable ultrasound scanner.
4.
Study indicates that exercise can help colon cancer survivors live as long as matched individuals
5.
Patients with chronic myeloid leukemia who take nilotinib are at higher risk for diabetes and hyperlipidemia.
1.
Liquid Biopsies in Hematology: A Window into the Disease
2.
Cancer Diagnosis in 2025: Innovations, Education, and Evolving Clinical Strategies
3.
Introducing the Corrected Calcium Calculator: A Revolutionary Tool in Medical Assessment
4.
Unlocking the Potential of Lymphocytes: Exploring the Role of These Immune System Cells
5.
Understanding Sideroblastic Anemia and its Symptoms
1.
International Lung Cancer Congress®
2.
Genito-Urinary Oncology Summit 2026
3.
Future NRG Oncology Meeting
4.
ISMB 2026 (Intelligent Systems for Molecular Biology)
5.
Annual International Congress on the Future of Breast Cancer East
1.
A Comprehensive Guide to First Line Management of ALK Positive Lung Cancer - Part VI
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part III
3.
Managing ALK Rearranged Non-Small Cell Lung Cancer with Lorlatinib - Part IV
4.
A Continuation to Deep Dive Into EGFR Mutation Positive Non-Small Cell Lung Cancer
5.
Nimotozumab Plus Chemo-radiotherapy v/s Placebo Plus Chemo-radiotherapy in Locally Advanced Nasopharyngeal Carcinoma
Address :
Hidoc Dr. Inc. | Delaware C Corp | 1309 Coffeen Ave. Suite 1200, Sheridan WY, 82801
Phone :
+1-415-463-3094
Email :
anishagadia@hidoc.co
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
To get started please enter your email ID
Join to enhance your clinical skills and gain specialized in-depth medical knowledge